ESTRO Announces Press Programme for 2008 Annual Congress.
BRUSSELS, Belgium, July 11 /PRNewswire/ --
- The European Society for Therapeutic Radiology and Oncology to Hold Press Conference With 4 Major Topics on Monday 15 September 2008.
More than 4,500 cancer and radiotherapy radiotherapy /ra·dio·ther·a·py/ (-ther´ah-pe) treatment of disease by means of ionizing radiation; tissue may be exposed to a beam of radiation, or a radioactive element may be contained in devices (e.g. specialists will gather in GE[micro]teborg this September for the 27th annual congress of ESTRO ESTRO European Society for Therapeutic Radiology and Oncology . ESTRO 27 is to be held between the 14th and 18th September 2008 at the GE[micro]teborg Convention Centre in GE[micro]teborg, Sweden.
The congress will include teaching sessions, lectures, presentations of major breakthroughs, posters and discussions dealing with the different areas covered by Radiotherapy such as physics, radiobiology, clinical radiotherapy and brachytherapy brachytherapy /brachy·ther·a·py/ (-ther´ah-pe) treatment with ionizing radiation whose source is applied to the surface of the body or within the body a short distance from the area being treated. . More than 1,500 abstracts have been submitted, which is the highest number ESTRO has ever received.
The congress will also present the largest industrial exhibition of radiotherapy in Europe with brand new materials exposed on 10,000 m2.
PRESS PROGRAMME SCHEDULE
Monday 15 September, 1.15 pm to 2.30 pm
Opening press conference
ESTRO's President, Vincent Gregoire will present the main sessions of the congress and will describe the latest moves and major happenings occurring in the different fields of Radiotherapy.
New clinical results in radio-oncology in 2008
Data on new phase III Noun 1. phase III - a large clinical trial of a treatment or drug that in phase I and phase II has been shown to be efficacious with tolerable side effects; after successful conclusion of these clinical trials it will receive formal approval from the FDA trial on various sites will be presented for the first time.
Swedish proton therapy Proton therapy is a type of particle therapy which utilizes a beam of protons to irradiate a tumor site. Introduction
Proton therapy is of interest because of its ability to accurately target and kill tumors, both near the surface and deep seated within the body, while project
Sweden will launch a new process that is unique in Europe for treating cancer. The concept of 'distributed competence' involves 8 Swedish university hospitals that perform treatment plans close to the patients' home, who are then treated in a single place, at the proton centre of the Skandion clinic.
Radiotherapy Information Centre
ESTRO is launching a unique radiotherapy information tool in Europe. Dedicated to radiotherapy professionals, but also to patients and the media, it will provide very useful data that can be adapted for use by different public mediums.
Notes to Editors
The European Society for Therapeutic Radiology and Oncology (ESTRO) was founded in 1980 and today, with more than 5,000 members, the society promotes Radiolotherapy among all disciplines in cancer treatment and research.
ESTRO provides educational and continuing professional development CPD is the means by which members of professional associations maintain, improve and broaden their knowledge and skills and develop the personal qualities required in their professional lives. programmes to oncologists and also disseminates research results, organises meetings and conferences for all professionals involved in delivering Radiotherapy - radio- therapists, biologists, physicists and oncology nurses - to improve patient care.
Press Office: Cecile Hardon firstname.lastname@example.org ESTRO Avenue E. Mounier, 83 - 1200 Brussels Belgium Tel: +32-2-761-06-51 http://www.estro.org
Press Office:, Cecile Hardon, email@example.com; ESTRO, Avenue E. Mounier, 83 - 1200 , Brussels, Belgium,Tel: +32-2-761-06-51